Source: Pharmabiz

NovImmune: Sobi, Novimmune select Honourees for 2019 NORD Rare Impact Award for Gamifant

Sobi and Novimmune SA have both been selected as honourees by the National Organization for Rare Disorders (NORD) for the 2019 Rare Impact Awards. The companies were nominated in the category of

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Erik Trock Jansen's photo - CEO of NovImmune

CEO

Erik Trock Jansen

CEO Approval Rating

88/100

Read more